Search Results - "Blot V"

The AI Innerve Algorithm: Automatic Reproducible Reading for Intraepidermal Nerve Fiber Density Analysis, a New Tool for Small‐Fiber Neuropathy Diagnosis.

Authors: Labeyrie, C. Lorenzo de Brionne, A. Trassard, O. et al.

Source: European Journal of Neurology. Apr2026, Vol. 33 Issue 4, p1-5. 5p.

Subjects: Inter-observer reliability, Algorithms, Skin biopsy, Immunofluorescence, Neuropathy

This result is not displayed to guests.
Login for full access.

Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib.

Authors: Horinouchi, H. Cho, B.C. Camidge, D.R. et al.

Source: Annals of Oncology. May2025, Vol. 36 Issue 5, p583-591. 9p.

573P LUMINATE-103: Real-world treatment patterns and outcomes of patients (pts) with epidermal growth factor receptor mutant (EGFR MU), non-squamous (NSQ) locally advanced/metastatic non-small cell lung cancer (a/mNSCLC): Pooled analysis of large US electronic health record (EHR) datasets

Authors: Cho, B.C. Xu, Q. Ng, S. et al.

Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1694-S1695. 2p.

515MO Phase Ib study of telisotuzumab vedotin (Teliso-V) and osimertinib in patients (Pts) with advanced EGFR-mutated (Mut), c-Met overexpressing (OE) non-small cell lung cancer (NSCLC): Final efficacy and safety updates.

Authors: Horinouchi, H. Cho, B.C. Camidge, D.R. et al.

Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1670-S1670. 1p.

387P Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib study.

Authors: Horinouchi, H. Goldman, J.W. Cho, B.C. et al.

Source: Annals of Oncology. Nov2022 Suppl 9, Vol. 33, pS1592-S1592. 1p.

1414TiP Evaluating telisotuzumab vedotin in combination with osimertinib in patients with advanced non-small cell lung cancer: A phase I/Ib study cohort.

Authors: Camidge, D.R. Goldman, J.W. Cole, G.W. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS894-S894. 1p.

EP-1622: Cyberknife® M6TM: peripheral dose evaluation in brain treatments.

Authors: Delaby, N. Bellec, J. Bouvier, J. et al.

Source: Radiotherapy & Oncology. Apr2016 Supplement 1, Vol. 119, pS755-S756. 1p.

Brain-infiltrated monocyte macrophages in a rat model of temporal lobe epilepsy: revisiting the pro-inflammatory paradigm.

Authors: Grabon W Gasmi N Lang A et al.

Source: Frontiers in immunology [Front Immunol] 2025 Dec 09; Vol. 16, pp. 1695856. Date of Electronic Publication: 2025 Dec 09 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non-Small Cell Lung Cancer: A Case Report.

Authors: Fox DA Tran C Blot V et al.

Source: Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2025 Feb 14; Vol. 8 (2), pp. 108-112. Date of Electronic Publication: 2025 Feb 14 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.

Authors: Lassman AB Pugh SL Wang TJC et al.

Source: Neuro-oncology [Neuro Oncol] 2023 Feb 14; Vol. 25 (2), pp. 339-350.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.

Authors: Minta AA Andre-Alboth J Childs L et al.

Source: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2020 Oct; Vol. 103 (4), pp. 1717-1725.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

Journal Info: Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Print Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE

A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers.

Authors: Fujita R Blot V Wong E et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2020 Jun 02; Vol. 21 (6), pp. 549-559. Date of Electronic Publication: 2020 Mar 19.

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.

Authors: Gymnopoulos M Betancourt O Blot V et al.

Source: Molecular oncology [Mol Oncol] 2020 Jan; Vol. 14 (1), pp. 54-68. Date of Electronic Publication: 2019 Dec 03.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.

Authors: Camidge DR Barlesi F Goldman JW et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 10; Vol. 41 (5), pp. 1105-1115. Date of Electronic Publication: 2022 Oct 26.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Prevalence of Chronic Hepatitis B Virus Infection among Children in Haiti, 2017.

Authors: Childs L Adrien P Minta AA et al.

Source: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2019 Jul; Vol. 101 (1), pp. 214-219.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

Journal Info: Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Print Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE

A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC.

Authors: Camidge DR Barlesi F Goldman JW et al.

Source: JTO clinical and research reports [JTO Clin Res Rep] 2021 Dec 04; Vol. 3 (1), pp. 100262. Date of Electronic Publication: 2021 Dec 04 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.

Authors: Malhotra J Nikolinakos P Leal T et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2021 Sep; Vol. 16 (9), pp. 1559-1569. Date of Electronic Publication: 2021 Feb 27.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Targeted sonodynamic destruction of glioblastoma cells using antibody-titanium dioxide nanoparticle conjugates.

Authors: Lee GP Willis A Pernal S et al.

Source: Nanomedicine (London, England) [Nanomedicine (Lond)] 2021 Mar; Vol. 16 (7), pp. 523-534. Date of Electronic Publication: 2021 Mar 04.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278111 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1748-6963 (Electronic) Linking ISSN: 17435889 NLM ISO Abbreviation: Nanomedicine (Lond) Subsets: MEDLINE

Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer.

Authors: Zoeller JJ Vagodny A Daniels VW et al.

Source: Breast cancer research : BCR [Breast Cancer Res] 2020 Nov 30; Vol. 22 (1), pp. 132. Date of Electronic Publication: 2020 Nov 30.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE